ITX:BMEIndustria de Diseno Textil, S.A. Analysis
Data as of 2026-03-10 - not real-time
€50.80
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Industria de Diseño Textil (ITX) is trading at €50.8, just above its technical support of €49.82 and well below the 20‑day SMA of €55.82, indicating short‑term price weakness but a potential floor. The RSI of 28.9 suggests the stock is oversold, while a bearish MACD histogram reinforces downward momentum, yet volume is increasing, hinting at possible buying interest. Fundamentally, the company posts a solid ROE of 32.7% and a healthy dividend yield of 2.18% with a 58% payout, supported by €11.3 bn of cash and modest debt levels.
The valuation appears fair – the forward P/E of 23.4x and P/B of 8.4x are high for a mature retailer but are justified by strong profitability, consistent revenue growth of ~5%, and an analyst consensus upside of 13%. With a low beta (~0.2) and a “Extreme Greed” market sentiment, the stock offers a balanced risk‑reward profile for investors seeking both income and modest capital appreciation.
The valuation appears fair – the forward P/E of 23.4x and P/B of 8.4x are high for a mature retailer but are justified by strong profitability, consistent revenue growth of ~5%, and an analyst consensus upside of 13%. With a low beta (~0.2) and a “Extreme Greed” market sentiment, the stock offers a balanced risk‑reward profile for investors seeking both income and modest capital appreciation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI indicates oversold conditions
- Price near technical support
- Increasing volume despite bearish MACD
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong cash position and manageable debt
- Attractive dividend yield with sustainable payout
- Analyst target upside of ~13% and fair valuation
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Robust brand portfolio and global footprint
- Consistent profitability and high ROE
- Dividend sustainability and long‑term earnings growth
Key Metrics & Analysis
Financial Health
Revenue Growth4.90%
Profit Margin15.33%
P/E Ratio26.2
ROE32.70%
ROA13.48%
Debt/Equity29.03
P/B Ratio8.4
Technical Analysis
TrendNeutral
RSI29.0
Support€49.82
Resistance€58.28
MA 20€55.82
MA 50€55.90
MA 200€48.85
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89
Valuation
Target Price€57.49
Upside/Downside13.16%
GradeFair
TypeBlend
Dividend Yield2.18%
Risk Assessment
Beta0.21
Volatility27.46%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.